Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 10NIH 2OTHER_GOV 1FED 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1Myocardial Infarction 1Metabolic Syndrome 1Diabetes Mellitus 1Cognitive Dysfunction 1Angina, Unstable 1

Interventions

Cisplatin 50Capecitabine 42apatinib 34Radiotherapy 33Oxaliplatin 33Gemcitabine 33Cyclophosphamide 32Drug Therapy 31Paclitaxel 30Carboplatin 29tislelizumab 27Irinotecan 27Fluorouracil 26Docetaxel 26Bevacizumab 23Surgical Procedures, Operative 21Nivolumab 19pembrolizumab 18fludarabine 18Metformin 16Exercise 16camrelizumab 15Radiation 15S 1 (combination) 14Control Groups 14Blood Specimen Collection 14Pemetrexed 13Standard of Care 12anlotinib 11Neoadjuvant Therapy 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Diet, Fat-Restricted × Clear all
NCT00924937 2021-06-03

CORDIOPREV

Hospital Universitario Reina Sofia de Cordoba

Phase NA Completed
1,002 enrolled

Angina, Unstable, Diabetes Mellitus, Myocardial Infarction, Neoplasms, Metabolic Syndrome, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡